puc-header

A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability

50 Pages Posted: 17 Jun 2019 Publication Status: Published

See all articles by Katerina Fagan-Solis

Katerina Fagan-Solis

University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center

Dennis A. Simpson

University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center

Rashmi J. Kumar

University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center

Luciano Martelotto

Memorial Sloan Kettering Cancer Center

Lisle E. Mose

University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center

Naim Rashid

University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center

Alice Y. Ho

Massachusetts General Hospital

Simon N. Powell

Memorial Sloan Kettering Cancer Center

Y. Hannah Wen

Memorial Sloan Kettering Cancer Center - Department of Pathology

Joel S. Parker

University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center

Jorge S. Reis-Filho

Memorial Sloan Kettering Cancer Center - Department of Pathology

John Petrini

Memorial Sloan Kettering Cancer Center - Molecular Biology Program

Gaorav Gupta

University of North Carolina at Chapel Hill - Department of Radiation and Oncology

More...

Abstract

SummaryThe Mre11-Rad50-Nbs1 complex is a DNA double strand break sensor that mediates a tumor suppressive DNA damage response (DDR) in cells undergoing oncogenic stress, yet the mechanisms underlying this effect are poorly understood. Using a novel genetically inducible mammary epithelial cell model, we demonstrate that Mre11 suppresses proliferation and DNA damage induced by diverse oncogenic drivers through a p53-independent mechanism. Expression of a hypomorphic mutant allele of Mre11 exacerbates oncogene-driven increases in R-loops and results in a copy number loss phenotype enriched in gene-coding regions that is revealed by whole genome sequencing of mammary hyperplasia and breast tumors. Mre11 complex dysfunction is identified in a subset of human triple-negative breast cancers, and is associated with increased sensitivity to DNA damaging therapy and inhibitors of ATR and PARP. Thus, deficiencies in the Mre11-dependent DDR drive proliferation and genome instability patterns in p53-deficient breast cancers, and represent an opportunity for therapeutic exploitation.

Keywords: Genome instability, DNA repair, Tumorigenesis, Oncogene, Proliferation, Breast Cancer

Suggested Citation

Fagan-Solis, Katerina and Simpson, Dennis A. and Kumar, Rashmi J. and Martelotto, Luciano and Mose, Lisle E. and Rashid, Naim and Ho, Alice Y. and Powell, Simon N. and Wen, Y. Hannah and Parker, Joel S. and Reis-Filho, Jorge S. and Petrini, John and Gupta, Gaorav, A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability (June 14, 2019). Available at SSRN: https://ssrn.com/abstract=3404264 or http://dx.doi.org/10.2139/ssrn.3404264
This version of the paper has not been formally peer reviewed.

Katerina Fagan-Solis

University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center

102 Ridge Road
Chapel Hill, NC 27514
United States

Dennis A. Simpson

University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center

102 Ridge Road
Chapel Hill, NC 27514
United States

Rashmi J. Kumar

University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center

102 Ridge Road
Chapel Hill, NC 27514
United States

Luciano Martelotto

Memorial Sloan Kettering Cancer Center

New York, NY 10065
United States

Lisle E. Mose

University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center

102 Ridge Road
Chapel Hill, NC 27514
United States

Naim Rashid

University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center

102 Ridge Road
Chapel Hill, NC 27514
United States

Alice Y. Ho

Massachusetts General Hospital

55 Fruit Street Boston
Boston, MA 02114
United States

Simon N. Powell

Memorial Sloan Kettering Cancer Center

New York, NY 10065
United States

Y. Hannah Wen

Memorial Sloan Kettering Cancer Center - Department of Pathology

New York, NY
United States

Joel S. Parker

University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center

102 Ridge Road
Chapel Hill, NC 27514
United States

Jorge S. Reis-Filho

Memorial Sloan Kettering Cancer Center - Department of Pathology ( email )

New York, NY
United States

John Petrini

Memorial Sloan Kettering Cancer Center - Molecular Biology Program

New York, NY 10065
United States

Gaorav Gupta (Contact Author)

University of North Carolina at Chapel Hill - Department of Radiation and Oncology ( email )

102 Ridge Road
Chapel Hill, NC 27514
United States

Click here to go to Cell.com

Paper statistics

Downloads
43
Abstract Views
1,131
PlumX Metrics